Drugmaker GlaxoSmithKline will tighten its continuing medical-education funding rules in 2010 with financial support going only to independently designed and executed programs, company officials said in a news release. “GSK will not support as many medical education programs, but we will continue funding those with the greatest potential to improve patient health,” says Deirdre Connelly, president of Glaxo North America. The move, she adds, is part of the drugmaker's ongoing effort to be more transparent in its business operations and interactions with healthcare providers. The new policy will restrict eligible CME grant applicants to academic medical centers and their affiliated teaching and patient-care institutions, as well as national professional medical associations. Glaxo says it will no longer fund CME delivered by commercial providers such as medical education and communication companies. The drugmaker will continue posting all approved grants to its company Web site. For more on this topic, please watch: “Video News: Are financial gifts from medical suppliers to docs jeopardizing patient care?”
Submit a letter to the Modern Physician Reader Blog. Please include your name, title, company and hometown. Modern Physician reserves the right to edit all submissions.